Product
Boya IVIG
1 clinical trial
1 indication
Indication
Primary Immunodeficiency DiseaseClinical trial
Efficacy, Safety and Pharmacokinetics of Boya Intravenous Immunoglobulin (IVIG) in Participants With Primary ImmunodeficiencyStatus: Not yet recruiting, Estimated PCD: 2025-04-30